Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue)
Date held: March 7th, 2019
Presented by: Dr. Kelvin Chan
Dr. Kelvin Chan gave a short explanation on what real-world evidence (RWE) is, how they can be used in cancer care and what benefits patients can get from the real-world evidence. He will also introduce the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration, which is a pan-Canadian collaboration working on developing a framework to generate and use real-world evidence to inform cancer drug funding decisions.
The webinar was followed by an interactive question & answer session.
The slides are available on our Slideshare account here.